[An impact of neuroprotective therapy on blood rheological and morphodensitometric parameters in patients with chronic cerebral ischemia].

Anisimova AV, Kolesnikova TI, Iutskova EV, Galkin SS, Zimin IA

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2014Cited by 1 (Europe PMC)

PMID25591521PepBankPUB-25591521

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. 5 results from people.

01HumanRandomized controlled trialEfficacy outcome
In chronic cerebral ischemia patients, Cerebrolysin had a reported positive effect on the clinical picture.
In plain wordsIn chronic cerebral ischemia patients, Cerebrolysin improved the clinical condition versus standard treatment alone.
Peptide
Cerebrolysin
Outcome
Not applicableClinical picture
Study
n = 300
Comparator
Standard treatment without Cerebrolysin
Outcome group
Neuroprotection · Nervous system and cognition
Studied dose
Dose not stated
Source sentences
Summary
Along with the total positive effect of cerebrolysin on the clinical picture
1 context sentence(design, population, supporting numbers)
Summary · context
Patients were randomized by disease stage and treatment (standard treatment with or without cerebrolysin).
Report a problemFND-2559152101
02HumanRandomized controlled trialEfficacy outcome
In chronic cerebral ischemia patients, Cerebrolysin improved erythrocyte morphodensitometric parameters.
In plain wordsIn chronic cerebral ischemia patients, Cerebrolysin improved measured red blood cell characteristics versus standard treatment alone.
Peptide
Cerebrolysin
Outcome
Not applicableErythrocyte morphodensitometric parameters
Study
n = 300
Comparator
Standard treatment without Cerebrolysin
Outcome group
Vascular function · Cardiovascular
Studied dose
Dose not stated
Source sentences
Summary
Along with the total positive effect of cerebrolysin on the clinical picture, additional mechanisms of its action (antiaggregant, antihypoxic and membranotropic) improved the erythrocyte morphodensitometric parameters, hemostatic, hemorheological and blood gas transport characteristics, in particula…
1 context sentence(design, population, supporting numbers)
Summary · context
Patients were randomized by disease stage and treatment (standard treatment with or without cerebrolysin).
Report a problemFND-2559152102
03HumanRandomized controlled trialEfficacy outcome
In chronic cerebral ischemia patients, Cerebrolysin improved hemostatic characteristics.
In plain wordsIn chronic cerebral ischemia patients, Cerebrolysin improved blood clotting characteristics versus standard treatment alone.
Peptide
Cerebrolysin
Outcome
Not applicableHemostatic characteristics
Study
n = 300
Comparator
Standard treatment without Cerebrolysin
Outcome group
Bleeding and clotting · Cardiovascular
Studied dose
Dose not stated
Source sentences
Summary
Along with the total positive effect of cerebrolysin on the clinical picture, additional mechanisms of its action (antiaggregant, antihypoxic and membranotropic) improved the erythrocyte morphodensitometric parameters, hemostatic, hemorheological and blood gas transport characteristics, in particula…
1 context sentence(design, population, supporting numbers)
Summary · context
Patients were randomized by disease stage and treatment (standard treatment with or without cerebrolysin).
Report a problemFND-2559152103
04HumanRandomized controlled trialEfficacy outcome
In chronic cerebral ischemia patients, Cerebrolysin improved hemorheological characteristics.
In plain wordsIn chronic cerebral ischemia patients, Cerebrolysin improved blood flow characteristics versus standard treatment alone.
Peptide
Cerebrolysin
Outcome
Not applicableHemorheological characteristics
Study
n = 300
Comparator
Standard treatment without Cerebrolysin
Outcome group
Vascular function · Cardiovascular
Studied dose
Dose not stated
Source sentences
Summary
Along with the total positive effect of cerebrolysin on the clinical picture, additional mechanisms of its action (antiaggregant, antihypoxic and membranotropic) improved the erythrocyte morphodensitometric parameters, hemostatic, hemorheological and blood gas transport characteristics, in particula…
1 context sentence(design, population, supporting numbers)
Summary · context
Patients were randomized by disease stage and treatment (standard treatment with or without cerebrolysin).
Report a problemFND-2559152104
05HumanRandomized controlled trialEfficacy outcome
In chronic cerebral ischemia patients, Cerebrolysin improved blood gas transport characteristics.
In plain wordsIn chronic cerebral ischemia patients, Cerebrolysin improved blood gas transport characteristics versus standard treatment alone.
Peptide
Cerebrolysin
Outcome
Not applicableBlood gas transport characteristics
Study
n = 300
Comparator
Standard treatment without Cerebrolysin
Outcome group
Blood oxygenation and oxygen transport · Cardiovascular
Studied dose
Dose not stated
Source sentences
Summary
Along with the total positive effect of cerebrolysin on the clinical picture, additional mechanisms of its action (antiaggregant, antihypoxic and membranotropic) improved the erythrocyte morphodensitometric parameters, hemostatic, hemorheological and blood gas transport characteristics, in particula…
1 context sentence(design, population, supporting numbers)
Summary · context
Patients were randomized by disease stage and treatment (standard treatment with or without cerebrolysin).
Report a problemFND-2559152105

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

Version 2Current
14 Oct 2026, 05:02 UTC
Study results updated
Version 1
14 Oct 2026, 01:46 UTC
First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

MeSH terms

PepBank is a research reference. Talk to a doctor before you use any peptide.